In conclusion, AITL differed from TFH-PTCL-NOS cases with respect to morphology, BCL-6 expression and RHOA mutation rate, although none of these features had clinical implications. The gene discussed is BCL6; the disease is angioimmunoblastic T-cell lymphoma.